HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Buchfelder Selected Research

Craniopharyngioma (Craniopharyngiomas)

10/2021Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study.
1/2018Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.
11/2017Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
12/2016Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
1/2016EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
10/2015BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
1/2014Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
2/2012Results after treatment of craniopharyngiomas: further experiences with 73 patients since 1997.
7/2011EGFR signaling regulates tumor cell migration in craniopharyngiomas.
9/2010Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Buchfelder Research Topics

Disease

86Neoplasms (Cancer)
05/2022 - 01/2000
31Glioma (Gliomas)
02/2022 - 03/2004
23Pituitary Neoplasms (Pituitary Adenoma)
05/2022 - 01/2003
17Adenoma (Adenomas)
12/2021 - 01/2000
15Pituitary ACTH Hypersecretion
01/2022 - 01/2006
15Brain Neoplasms (Brain Tumor)
10/2021 - 02/2003
15Craniopharyngioma (Craniopharyngiomas)
10/2021 - 07/2005
15Glioblastoma (Glioblastoma Multiforme)
10/2021 - 05/2003
13Epilepsy (Aura)
10/2022 - 02/2003
13Acromegaly
05/2022 - 01/2007
9Hypoxia (Hypoxemia)
05/2022 - 10/2018
7Meningioma (Meningiomas)
12/2020 - 07/2005
5Edema (Dropsy)
10/2021 - 06/2008
5Necrosis
10/2021 - 10/2018
5Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020 - 09/2009
5Hydrocephalus (Hydrocephaly)
12/2018 - 01/2012
5Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
11/2017 - 01/2012
4Chronic Pain
06/2022 - 09/2019
4Prolactinoma (Prolactinomas)
01/2019 - 01/2000
4Partial Epilepsies (Epilepsy, Partial)
01/2018 - 09/2007
4Residual Neoplasm
04/2017 - 08/2007
4Brain Edema (Cerebral Edema)
06/2016 - 06/2008
4Brain Injuries (Brain Injury)
06/2016 - 09/2009
4Cushing Syndrome
03/2015 - 04/2006
4Hippocampal Sclerosis
07/2014 - 05/2008
3Pain (Aches)
06/2022 - 08/2019
3Seizures (Absence Seizure)
01/2022 - 10/2013
3Drug Resistant Epilepsy
11/2021 - 02/2012
3Obesity
10/2021 - 05/2013
3Carcinogenesis
12/2020 - 07/2005
3Hemorrhage
08/2019 - 08/2008
3Trigeminal Neuralgia (Tic Douloureux)
08/2019 - 10/2008
3ACTH-Secreting Pituitary Adenoma
01/2019 - 03/2015
3Headache (Headaches)
01/2019 - 07/2010
3Intracranial Aneurysm (Cerebral Aneurysm)
11/2017 - 02/2014
3Hypophysitis
11/2017 - 07/2006
3Central Nervous System Cysts (Suprasellar Cyst)
01/2016 - 12/2006
2Nervous System Diseases (Neurological Disorders)
10/2022 - 01/2022
2Disease Progression
05/2022 - 02/2012
2Temporal Lobe Epilepsy
01/2022 - 10/2013
2Weight Loss (Weight Reduction)
10/2021 - 05/2013
2Neuroinflammatory Diseases
08/2021 - 09/2019
2Inappropriate ADH Syndrome (SIADH)
07/2020 - 04/2016

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
02/2022 - 03/2013
16Pharmaceutical PreparationsIBA
01/2022 - 08/2009
14Oxygen (Dioxygen)IBA
05/2022 - 01/2017
13Adrenocorticotropic Hormone (ACTH)FDA Link
01/2022 - 04/2006
9Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2000
9pegvisomantFDA LinkGeneric
12/2018 - 01/2007
7Hormones (Hormone)IBA
12/2021 - 01/2003
6Glutamic Acid (Glutamate)FDA Link
10/2022 - 09/2014
6Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2022 - 04/2008
6ProlactinIBA
12/2021 - 01/2000
6Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 12/2014
6ErbB Receptors (EGF Receptor)IBA
01/2019 - 05/2003
6Growth Hormone (Somatotropin)IBA
01/2016 - 04/2008
5Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 04/2006
5Messenger RNA (mRNA)IBA
08/2017 - 03/2004
5beta CateninIBA
05/2010 - 07/2005
4GlucocorticoidsIBA
01/2022 - 07/2006
4Transcription Factors (Transcription Factor)IBA
12/2021 - 11/2018
4Sulfasalazine (Azulfidine)FDA LinkGeneric
10/2021 - 01/2015
4Biological ProductsIBA
09/2021 - 05/2006
4EnzymesIBA
05/2021 - 07/2010
4Ubiquitin-Specific ProteasesIBA
01/2019 - 07/2015
4Dopamine Agonists (Dopamine Agonist)IBA
01/2019 - 01/2000
4Insulin-Like Growth Factor I (IGF-1)IBA
12/2017 - 08/2010
4Octreotide (Sandostatin)FDA LinkGeneric
12/2017 - 04/2006
4Small Interfering RNA (siRNA)IBA
11/2016 - 06/2008
4CateninsIBA
01/2015 - 10/2010
3Somatostatin Receptors (Somatostatin Receptor)IBA
05/2022 - 01/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 01/2014
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2022 - 10/2014
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2021 - 01/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 05/2003
3CytokinesIBA
09/2019 - 05/2003
3Amino Acid Transport System X-AG (Glutamate Transporter)IBA
06/2016 - 06/2008
3Peptides (Polypeptides)IBA
02/2016 - 07/2005
3Neuroprotective AgentsIBA
02/2015 - 05/2006
3Choline (Choline Chloride)IBA
08/2012 - 04/2007
3N-acetylaspartate (N-acetyl aspartate)IBA
08/2012 - 04/2007
3AntibodiesIBA
03/2010 - 01/2003
3Protons (Proton)IBA
08/2008 - 04/2007
2LeptinIBA
12/2020 - 09/2019
2ChemokinesIBA
12/2020 - 09/2019

Therapy/Procedure

47Therapeutics
06/2022 - 05/2004
17Radiotherapy
12/2021 - 01/2009
6Drug Therapy (Chemotherapy)
10/2021 - 01/2009
4Aftercare (After-Treatment)
01/2021 - 09/2010
4Craniotomy
06/2019 - 01/2008
4Ventriculoperitoneal Shunt
12/2018 - 01/2012
4Operative Surgical Procedures
03/2016 - 11/2002
4Decompression
01/2016 - 10/2005
3Injections
01/2022 - 01/2000
3Endoscopes
06/2019 - 01/2016
3Electrodes (Electrode)
01/2019 - 10/2016
3Combined Modality Therapy
12/2017 - 08/2014
3Lasers (Laser)
11/2017 - 07/2009
2Deep Brain Stimulation
06/2022 - 01/2022
2Adrenalectomy
03/2021 - 01/2018